Dutch Court Again Restricts Wingtech's Interference in Nexperia's Operations
nashnova research
An Amsterdam appeals court ruled that Wingtech Technology violated a prior judicial order, imposing further restrictions on founder Zhang Xuzheng and Nexperia's China operations from interfering with the company. The Chinese-owned European chipmaker is sliding toward a de facto split — and who ends up with control will reshape how cross-border semiconductor assets are governed.
What did the court actually rule?
The Dutch court found that Wingtech and related parties violated a prior judicial order through recent conduct — a second breach after the initial intervention.
The court tightened its grip: founder Zhang Xuzheng, Nexperia's China operations, and associated executives are now barred from interfering with Nexperia's normal business activities. Violators face significant fines.
This means → Wingtech's actual control over Nexperia has been stripped away layer by layer — voting rights frozen, CEO suspended, and now even indirect operational influence is blocked.
How did this dispute reach this point?
In September 2025, the Dutch government intervened in Nexperia's governance. The court froze Wingtech's voting rights, placed its shares under court-appointed administrators, and suspended Zhang Xuzheng as CEO.
Nexperia then sued Wingtech in the Netherlands for roughly $2 billion, alleging Wingtech ran Nexperia's China operations independently, outside the company's governance framework, causing substantial losses. Wingtech denies all allegations.
In plain terms = this is not a routine shareholder dispute — it is a European state using judicial power to sever a Chinese parent company from a chip asset on its soil.
Are the administrators looking for a new buyer?
Court-appointed administrators Guido Dierick and Arnold Croiset van Uchelen said they would broaden outreach to potential investors to gauge interest in acquiring a majority or minority stake in Nexperia.
But the administrators were clear: no decision has been made to reduce Wingtech's shareholding — whether to sell, and how much, remains open.
The administrators warned that restoring Wingtech's control would jeopardize Nexperia's operations, especially as export controls tighten across Nexperia's key markets.
This means → the administrators' position is now unmistakable — Wingtech's path back to control is effectively blocked, and outside capital is the only exit being seriously discussed.
How far has Nexperia's China business gone on its own?
Nexperia China CEO John Chang said publicly that the China business has localized its entire supply chain — product definition, R&D, and manufacturing can all be completed domestically.
Its 12-inch wafer platform — the mainstream production-line standard for chipmaking — now covers all product categories, with partnerships with Chinese foundries. Lead times for some components dropped from 12–16 weeks to 4–6 weeks.
In plain terms = Nexperia China can already run without headquarters — that is both a bargaining chip and hard evidence that the split is already a fact on the ground.
How is headquarters responding?
Nexperia interim CEO Stefan Tilger said the group has expanded packaging capacity in Malaysia to offset declining output from the China business, but still cannot fully meet global demand.
Tilger also left a door open: the independently operated China business could potentially rejoin the group in the future. He noted Wingtech remains the owner, and even a permanent separation would not necessarily extinguish its right to fair compensation.
This reflects a headquarters preparing for two outcomes simultaneously — reintegration, or a clean break followed by a payout to Wingtech.
What comes next?
Wingtech already rejected a restructuring proposal that would have transferred control of the non-China business to outside investors while letting Wingtech keep the China operations.
The administrators' renewed investor outreach means the deadlock will be broken by one question: who is willing to come in, at what price, and for how much control.
This means → the endgame of this dispute will not be decided in court but at the deal table — yet each successive court ruling compresses Wingtech's negotiating room further.
市场有风险，内容仅供研究参考，不构成投资建议。